Rima Mariam, Oueslati Saoussen, Dabos Laura, Daaboul Dina, Mallat Hassan, Bou Raad Elie, Achkar Marcel, Mawlawi Osman, Bernabeu Sandrine, Bonnin Rémy A, Girlich Delphine, Osman Marwan, Hamze Monzer, Naas Thierry
Team ReSIST, INSERM U1184, School of Medicine, Université Paris-Saclay, LabEx LERMIT, 94270 Le Kremlin-Bicêtre, France.
Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli 1300, Lebanon.
Antibiotics (Basel). 2022 Sep 22;11(10):1295. doi: 10.3390/antibiotics11101295.
Carbapenem resistance (CR) is an emerging health issue. Epidemiological surveys on carbapenem-resistant Gram-negative bacilli (CR-GNB) in Lebanon remain scarce. In this study, we determined the prevalence of CR-GNB isolated between 2015 to 2019 in three hospitals in northern Lebanon: 311 CR- (out of 11210; 2.8%), 155 CR- (out of 1034; 15%) and 106 CR- (out of 184; 57.6%) were identified. CR mechanisms were determined for 146 randomly chosen isolates: the Carba NP test revealed an enzymatic resistance to carbapenems in 109 isolates (out of 146, 74.7%). Produced carbapenemases were evaluated by the NG-Test Carba5, NG-Test OXA-23 immunochromatographic assays and PCR. Carbapenemase-producing (CP) expressed -like, -like and -like genes and CP- expressed -like and -like genes, whereas CP- expressed -like genes. The NG-Test Carba5 results were confirmed by PCR sequencing and revealed several variants, such as NDM-19, VIM-62 and OXA-162, never described so far in Lebanon. Isolates with discordant results were sequenced by WGS and highlighted novel variants of the natural oxacillinases of : -like genes. Their role in carbapenem resistance should be further studied. Overall, our findings highlight an alarming situation and encourage health care centers to establish performant registration systems that could help in limiting resistance spread.
碳青霉烯类耐药性(CR)是一个新出现的健康问题。黎巴嫩针对耐碳青霉烯类革兰氏阴性杆菌(CR-GNB)的流行病学调查仍然很少。在本研究中,我们确定了2015年至2019年黎巴嫩北部三家医院分离出的CR-GNB的患病率:分别鉴定出311株CR-(11210株中;2.8%)、155株CR-(1034株中;15%)和10株CR-(184株中;57.6%)。对146株随机选择的分离株进行了CR机制检测:Carba NP试验显示109株分离株(146株中;74.7%)对碳青霉烯类具有酶抗性。通过NG-Test Carba5、NG-Test OXA-23免疫色谱分析和PCR对产生的碳青霉烯酶进行评估。产碳青霉烯酶(CP)的菌株表达了blaNDM-like、blaVIM-like和blaOXA-like基因,而CP-菌株表达了blaOXA-like和blaIMP-like基因,而CP-菌株表达了blaOXA-like基因。NG-Test Carba5结果通过PCR测序得到证实,并揭示了几种变体,如NDM-19、VIM-62和OXA-162,这些变体在黎巴嫩迄今尚未被描述过。结果不一致的分离株通过全基因组测序(WGS)进行测序,并突出显示了blaOXA-like基因的天然氧青霉烯酶的新变体。它们在碳青霉烯类耐药性中的作用应进一步研究。总体而言,我们的研究结果突出了一个令人担忧的情况,并鼓励医疗保健中心建立高效的登记系统,这有助于限制耐药性的传播。